Cannabis News

Emerald Health Therapeutics Gets Tier 1 Listing on TSXV

Cannabis Investing News

Emerald Health Therapeutics announced it met the requirements of the TSX Venture Exchange to be upgraded into a Tier 1 company.

Emerald Health Therapeutics (TSXV:EMH; OTCQX:EMHTF) announced it met the requirements of the TSX Venture Exchange to be upgraded into a Tier 1 company.

As quoted in the press release:

The TSX Venture Exchange classifies issuers as “Tier 1” or “Tier 2” based on standards regarding historical financial performance, stage of development, and financial resources. Tier 1 is the highest tier of the TSX-V and is reserved for more advanced issuers with greater financial resources. Tier 1 issuers benefit from less stringent filing requirements.

“Our team has been working diligently to meet our stated cannabis production scaling objectives, progress our product innovation strategy, and advance a differentiating marketing plan. In conjunction with these efforts our valuation and financial resources have been increasing and we are pleased that our accomplishments have allowed us to attain a higher listing status on the TSX Venture Exchange,” said Chris Wagner, CEO of Emerald Health Therapeutics.

Click here to read the full press release.

Source: globenewswire.com

MARKETS

Markets
TSX19384.92-100.97
TSXV570.27+5.50
DOW33147.25-73.55
S&P 5003839.50-9.78
NASD10466.48-11.61
ASX7038.70+18.60

COMMODITIES

Commodities
Gold1836.62+7.46
Silver24.33+0.25
Copper3.84+0.03
Palladium1795.64+1.16
Platinum1081.51+13.51
Oil79.53-0.73
Heating Oil3.24-0.05
Natural Gas4.10-0.37

DOWNLOAD FREE REPORTS

×